$8.45
-0.02[-0.24%]
At close: Apr 26
$8.45
0[0.00%]
After Hours: 7:50PM EDT
Acrivon Therapeutics
(NASDAQ:ACRV)Acrivon Therapeutics Stock (NASDAQ:ACRV), Quotes and News Summary
Acrivon Therapeutics Stock (NASDAQ: ACRV) stock price, news, charts, stock research, profile.
| Open | $8.530 |
| Close | $8.460 |
| Volume / Avg. | 276.495K / 746.574K |
| Day Range | 8.200 - 8.779 |
| 52 Wk Range | 3.190 - 14.300 |
| Market Cap | $260.868M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 52 |
| Short Interest | 2.33% |
| Days to Cover | 7.72 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Acrivon Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Acrivon Therapeutics (ACRV) stock?
You can purchase shares of Acrivon Therapeutics (NASDAQ: ACRV) through any online brokerage.
Who are Acrivon Therapeutics's (ACRV) competitors?
Other companies in Acrivon Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Renovaro (NASDAQ:RENB), Inozyme Pharma (NASDAQ:INZY), Inovio Pharmaceuticals (NASDAQ:INO) and Adaptimmune Therapeutics (NASDAQ:ADAP).
What is the target price for Acrivon Therapeutics (ACRV) stock?
The latest price target for Acrivon Therapeutics (NASDAQ: ACRV) was reported by BMO Capital on Friday, April 26, 2024. The analyst firm set a price target for 25.00 expecting ACRV to rise to within 12 months (a possible 195.86% upside). 17 analyst firms have reported ratings in the last year.
Current Stock Price for Acrivon Therapeutics (ACRV)?
The stock price for Acrivon Therapeutics (NASDAQ: ACRV) is $8.45 last updated April 26, 2024 at 7:50 PM EDT.
Does Acrivon Therapeutics (ACRV) pay a dividend?
There are no upcoming dividends for Acrivon Therapeutics.
When is Acrivon Therapeutics (NASDAQ:ACRV) reporting earnings?
Acrivon Therapeutics’s Q1 earnings are confirmed for Friday, May 10, 2024.
Is Acrivon Therapeutics (ACRV) going to split?
There is no upcoming split for Acrivon Therapeutics.
What sector and industry does Acrivon Therapeutics (ACRV) operate in?
Acrivon Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.